Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
That's what I was thinking; let's get to a penny first. Also, get Creditum to an IPO which should create tremendous market awareness for ARGQ. NDAI!
The first quarter ended on March 31, 2019. The 1Q'19 10-Q is due on April 15, 2019. GLTA!
Wait until 1Q'19 10-Q. Profits will start Quarter over Quarter. 2019 will be a great year for SIPC!
$$$$$$$$$$$$$$$$$$ SIPC $$$$$$$$$$$$$$$$$$$$
Sipp/Major Hemp will lead the competition, whatever the beer!
With all this good news, maybe ARGQ will close a couple of Funds and a IPO for a chaser. LOL!
Yes we have! Zzzzzzzz.
All I know is each production run is larger based on expansions and locations added. I expect the Revenue growth will start to be reflected in the 1Q'19 10-Q. 1Q-19/1Q'18.
You're right! My apologies as it was dr10 suggesting Itonis should get Emesyl into Pro Bass and Cabellas' shops. Reference is to 9/17 postings.
I thought it was the third run of MHIPA?
Still the Buys are 700,000 and the Sells are 3,300,000. BTW, what happened to the Bass Pro Shops/Cabella stores stocking Emesyl in their stores? You posted a year ago that news updates were coming. Hmm!
Klas Strom is a very bright IR man. His statement is very well written and I'm excited by ARGQ's part in their future. I hope the Creditum IPO is in the near future too.
$$$$$$$$$$$$$$$$ ARGQ $$$$$$$$$$$$$$$$$$
Ditto! GLTA!
Exactly! It would be a nightmare for stockholders. I guess I'll hold for at least .18 PPS. GLTA!
A reverse split at this PPS would be disastrous. I'd wait for a "Proof of Concept". Management has to close Funds and generate growth in each one. ARGQ must show a much improved Revenue and Profit before a Capital conversion. They will usually work at a higher PPS and in anticipation of moving to a higher exchange.
So far everything Viewmont has posted is already known (On-line sites) and Zycam which is not part of Itonis. If that's all you have, then there's nothing new unless you provide your proof. Investors here know the company's website and its contents. GLTA!
I would like to know why Sales decreased from Year 2017 to Year 2018? The company had two beers for part of 2018 with more locations in Colorado and Illinois? But, reports should correct itself with mass distribution in 2019. GLTA!
Fair enough! But right now I'd think CT's progress is an underperformed entity. GLTA for 2019!
But not today! The volume is -0-. I wonder whether the Emesyl in the "big box" pharmacies are in storage and not yet put out on the shelves. LOL!
Still waiting for reports of quarter over quarter growth which will be shown during 2019. Products, Partnerships and Expansion!
$$$$$$$$$$$$$$$ SIPC $$$$$$$$$$$$$$$$$$
Management has used a "bait and switch" method to entice stockholders for several years now. Change the name of the company from Global Equity International to Argentum 47 (?) to focus on the acquisition of Funds. Promoted excellent financing to coverup lack of Revenue generated (Consulting fees, IPOs, etc.) The financing is nothing more than a "share financing plan" at a respectable interest rate. Regarding personnel, what ever happened to James Goldie and Kevin Wynn? They were both more qualified than the recent announcement. Management has also promoted a monthly increase in business at Cheshire Trafford that will exponentially grow the Fund. Hasn't happened! GTAL?
The last PR per the Itonis website was 9/18/2018!
If they're in the major pharmacies, why no PR to announce it?
Let's see what effect the advertising has on Sales/Revenue. Emesyl is a fine product that must be made available in all venues. GLTA!
SIPC move UP imminent within next two months. Distribution of CBD beer and major expansion will support PPS rise. NDAI!
$$$$$$$$$$$$$$$$$ SIPC $$$$$$$$$$$$$$$$$$$
I wish a million people felt the same way you do. The sales of Emesyl and Emesyl Plus have stagnated. The reviews were very good, percentage wise but they like the product has not grown. I wonder if Zycam would have been such a success if just sold "on line". Years ago there were to be 10,000 commercials for Emesyl that never materialized. Recently, Mr. Pidliskey stated advertising is too expensive. Maybe, Walmart is not acting in good faith with their suppliers, but there are many reputable chains to do business with. For example, CVS, Rite Aid and Walgreens.
We can talk a "blue streak" of projections, but only accomplishments will move the PPS UP. Isn't that the reason we're invested in this company? Close some Funds ASAP! NOW!
Similar to the client base which keeps on changing. Sad situation!
No growth from Aurum and other business introducer; no Funds closed. What is management doing? LOL!
I'm confident management will eventually issue a Form 10-K for 2018. I'll be looking for the significant growth of CT over the 40 million commencement value. GLTA!
Yes, as a financial company management should take a look at the anemic PPS and volume their efforts have produced. Projections and optimistic outlooks mean nothing until realized.
That's a "forwarding looking" statement that remains to be seen. Management must multi-task with the growth of Cheshire Trafford by closing additional Funds like the Isle of Man. Also, concentrations include consulting and IPO work. GLTA!
It's due now, but as you posted, there could be extraordinary items to include in the year end report. GLTA!
Double digits is a reality based on Sipp's products, partnerships and expansion which ultimately could be international. I'm waiting for Major Hemp's CBD beer and MH in California.
$$$$$$$$$$$$$$$ SIPC $$$$$$$$$$$$$$$$$$
I hope the 10-K will already show Revenue and Value growth for Cheshire Trafford as of 12/31/2018. A positive forward looking statement on the future IPO of Creditum would be encouraging. Also, an update of the status of active clients with projected and earned commissions should be included. GLTA!
In the original 8-k regarding the financing and acquisition of funds, there was a stipulation that the tranches could be used for debt reduction, working capital and the acquiring of firms with funds under management. Where do you think the money is being spent? ARGQ!
Exactly! Hope springs eternal! Close some Funds!
I see the conversions from the 8-ks. All ARGQ has to do now is close at least another Fund and complete an IPO for Creditum. We also need to know the progress the investor introducing firms have made in growing the value of Cheshire Trafford.
I agree! The 1Q'2019 will have a full three months of sales from Major Hemp HIPA.
$$$$$$$$$$$$$$$$$$ SIPC $$$$$$$$$$$$$$$$$$$$
So the conversion would be at .02 and it would move the PPS??? You did mention a conversion for this quarter. If not, please clarify your earlier post. TU!
Conversion happened at .0038 PPS? Hmm!
SIPC must report good Revenue growth first and it will push the PPS higher. Form 10-K due EOM. Revenues will break records quarter over quarter. I'm particularly interested in 1Q'19.
$$$$$$$$$$$$$$ SIPC $$$$$$$$$$$$$$$$$$$$